Cooperative Agreement W58P052220013

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

This Cooperative Agreement award for $4,603,542, provided by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750), aims to assess domestic production capabilities for pharmaceutical products used by the U.S. military health system. The project will be led by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a nonprofit organization with expertise in supporting military...

The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution...

This federal Cooperative Agreement award, provided by the Department of Defense (DOD) under the Defense Production Act (DPA) Title III Program (CFDA 12.777), will fund Constellium Muscle Shoals LLC to expand U.S. aluminum casting capacity. The $54,919,400 award, granted on July 22, 2024, aims to create, maintain, protect, expand, or restore domestic industrial base capabilities essential for national defense. The funding will support efforts to reduce reliance on foreign sources and strengthen...

The U.S. Department of Defense, through the Defense Production Act (DPA) Title III program (CFDA 12.777), awarded a $20,539,361.07 Cooperative Agreement to Northcliff Resources LTD. on Apr 29, 2025. The award is intended to fund a feasibility study update to support the domestic production of tungsten, a critical material for national defense. The project aims to create, maintain, protect, expand, or restore domestic industrial base capabilities essential for U.S. national security and reduce...

This $8.8 million Economic Development Administration Project Grant will support the Advanced Pharmaceutical Manufacturing Cluster led by the Virginia Biotechnology Research Partnership Authority to boost Virginia's domestic pharmaceutical supply chain. Funded projects include expanding wet lab space in Central Virginia to develop a pharmaceutical manufacturing corridor and critical infrastructure investments in Petersburg. The award will also catalyze a partnership between Virginia Commonwealth...

The Washington Headquarters Service, under the Defense Production Act (DPA) Title III program (CFDA 12.777), awarded a $43,436,608 Cooperative Agreement to Global Advanced Metals USA Inc. on September 20, 2024. This award focuses on establishing low-cost domestic production capabilities for high-purity niobium, a critical material for defense applications. The goal is to reduce reliance on foreign sources of strategic materials and support the expansion of Global Advanced Metals USA Inc.'s...

The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...

This $24.5 million Economic Development Administration Project Grant supports the Advanced Pharmaceutical Manufacturing Cluster led by the Virginia Biotechnology Research Partnership Authority to boost Virginia's domestic pharmaceutical supply chain. Funded projects will expand wet lab space and critical infrastructure in Central Virginia to develop an emerging pharmaceutical manufacturing corridor and engage local businesses to enhance the regional supply chain. The investment will also...

The Department of Defense (DOD) awarded a $10,293,760.41 Cooperative Agreement to Synthio Chemicals Inc. under the Defense Production Act (DPA) Title III Critical Chemicals Production program (CFDA 12.777). The award, dated December 20, 2023, supports Synthio's research, development, testing, manufacturing, and supply capabilities for critical chemicals important to national defense. Synthio, a leading manufacturer of fine and specialty chemicals, will leverage its expertise in advanced...